Increased acetylcholinesterase activity in selected regions of rat brain after chronic (−)-Deprenyl administration
- 15 Downloads
(−)-Deprenyl, 0.05, 1.0, 2.0, and 10.0 mg/kg body weight, was administered intraperitonially to Wistar rats for 30 days. The activity of acetylcholinesterase, and monoamine oxidase A and B were assayed in different brain regions. After the experimental period acetyl cholinesterase activity was found to be significantly increased in frontal cortex [P<0.001] and hippocampus [P<0.001] but not in striatum and brainstem at 0.1, 1.0, and 2.0 mg/kg dose, the maximum increase being at 0.1 mg/kg dose. Monoamine oxidase B activity was inhibited by more than 90% at 1.0, 2.0, and 10.0 mg/kg dose while 0.05 and 0.1 dose inhibited only about 55% and 70% respectively. Monoamine oxidase A activity was inhibited to more than 70% at 1.0 mg dose and to more than 90% at 2.0 and 10.0 mg/kg dose. At 0.05 and 0.1 mg/kg dose monoamine oxidase A activity was not significantly altered.
Key Words(−)-Deprenyl rat brain regions AChE MAO-A MAO-B
Unable to display preview. Download preview PDF.
- 2.Piccinin, G. L., Finali, G., and Piccirilli, M. 1990. Neurosychological effects of L-deprenyl in Alzheimer's type dementia. Clin. Neuropharmacology 13:147–163.Google Scholar
- 10.Peterson, I. A., Juorio, A. V., Berry, M. D., and Zhu, M. Y. 1991. Inhibition of monoamine oxidase-B by (−) deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in rat striatum. J. Pharmacol. Exp. Therap. 258: 1019–1026.Google Scholar
- 12.Langston, J. W. 1988. Pages 75–85 in Jankevic J (ed.) Parkinson's disease and movement disorders. Baltimore, urban and schwarzenberg.Google Scholar
- 13.Carrillo, M. C., Kanai, S., Nokubo, M., Ivy, G. V., Sato, Y., and Kitani, K. 1992. (−) Deprenyl increases activities of superoxide dismutase and catalase in striatum but not hippocampus: The sex and age related differences in the optimal dose in the rat. Exp. Neurol. 116:286–294.PubMedCrossRefGoogle Scholar
- 15.Dunnett, S. B. and Fibiger, H. C. 1993. Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer's dementia. In Cholinergic function and dysfunction. Progress in Brain Research, (ed. Cuello, A. C.) pp 413–420, Elsevier, Amsterdam.Google Scholar
- 23.Knoll, J. 1981. The pharmacology of selective MAO inhibitors. Pages 54–65, in Monoamine Oxidase Inhibitors—The state of the Art. Youdim M. B. H. and Payke, S (eds.), Wiley and Sons, Chicheste.Google Scholar